Cytovia, Cellectis expand partnership to boost collaboration in China

By The Science Advisory Board staff writers

November 22, 2021 -- Cytovia Therapeutics and Cellectis have expanded their partnership on transcription activatorlike effector nuclease (TALEN) gene-edited iNK (NK cells derived from induced pluripotent stem cells, or iPSC) to allow for a broader collaboration in China.

Cellectis will continue its development of a new TALEN, which Cytovia uses to edit iPSCs, according to the two firms. The collaboration now includes a new chimeric antigen receptor target, which will be developed in China by CytoLynx Therapeutics, Cytovia's joint venture.

Cellectis will receive $20 million in Cytovia stock in addition to $805 million in development, regulatory, and sales milestones plus royalties, the two firms said.

Cellectis, Sanofi partner on UCART clinical trials
Sanofi has agreed to supply anti-CD52 monoclonal antibody alemtuzumab for use in a lymphodepleting regimen in Cellectis-sponsored universal chimeric antigen...
Cytovia ramps up production of NK cells ahead of trials
Cytovia Therapeutics has signed two agreements for research and development and manufacturing operations to move the company's chimeric antigen receptor-natural...
Cytovia, Cellectis partner on gene-edited NK cells
Cytovia Therapeutics and Cellectis have entered into a strategic research and development collaboration to develop gene-edited natural killer (NK) and...
Cytovia licenses CAR NK tech to NCI
Cytovia Therapeutics has signed a licensing agreement with the National Cancer Institute (NCI), part of the National Institutes of Health, to apply its...

Copyright © 2021

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter